 DALLAS and FORT WORTH, Texas, Nov. 02, 2020 GLOBE NEWSWIRE -- Neos Therapeutics, Inc. Nasdaq: NEOS, a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its third quarter 2020 financial results at the opening of U.S. financial markets on Monday, November 9, 2020. Neos management will host a conference call and live audio webcast to discuss these results and provide a company update at 8:30 a.m. ET that same day. 